Suppr超能文献

尿桑葚细胞和桑葚体是检测迟发型法布里病的有用工具。

Urinary mulberry cells and mulberry bodies are useful tool to detect late-onset Fabry disease.

作者信息

Shimohata Homare, Maruyama Hiroshi, Miyamoto Yasunori, Takayasu Mamiko, Hirayama Kouichi, Kobayashi Masaki

机构信息

Department of Nephrology, Tokyo Medical University Ibaraki Medical Center, 3-20-1 Chuo, Ami, Inashiki, 300-0395, Ibaraki, Japan.

出版信息

CEN Case Rep. 2017 Nov;6(2):148-151. doi: 10.1007/s13730-017-0262-5. Epub 2017 Jun 7.

Abstract

Fabry disease is an X-linked lysosomal storage disorder caused by a lack of α-galactosidase A activity, which leads to the accumulation of globotriaosylceramide in various organs. A complete lack of α-galactosidase A activity in a hemizygous male is the classical phenotype, and some hemizygous males show primarily cardiac and/or renal symptoms that appear in adulthood; this is called the variant type or the late-onset type. The kidney and heart are the major target organs, with damage to these organs related to mortality. Thus, in Fabry patients, early detection and early treatment are critical to longevity. Here, we present a 55-year-old Japanese male patient who was diagnosed with late-onset Fabry nephropathy with cardiomyopathy but with no abnormal urinary findings except for urinary mulberry cells and mulberry bodies. In spite of the absence of abnormal urinary findings, the light microscopic and electron microscopic pathological findings showed extensive deposition of globotriaosylceramide to podocytes. In this paper, we propose that the presence of mulberry cells and mulberry bodies can be used for the earlier detection of Fabry nephropathy, especially the late-onset type.

摘要

法布里病是一种X连锁溶酶体贮积症,由α-半乳糖苷酶A活性缺乏所致,导致球三糖神经酰胺在多个器官蓄积。半合子男性完全缺乏α-半乳糖苷酶A活性是典型表型,部分半合子男性主要表现为成年期出现的心脏和/或肾脏症状;这被称为变异型或迟发型。肾脏和心脏是主要靶器官,这些器官的损害与死亡率相关。因此,在法布里病患者中,早期检测和早期治疗对延长寿命至关重要。在此,我们报告一名55岁的日本男性患者,他被诊断为迟发型法布里肾病合并心肌病,但除了尿桑葚细胞和桑葚体外,尿液检查无异常发现。尽管尿液检查无异常发现,但光镜和电镜病理检查结果显示球三糖神经酰胺广泛沉积于足细胞。在本文中,我们提出桑葚细胞和桑葚体的存在可用于法布里肾病尤其是迟发型的早期检测。

相似文献

1
Urinary mulberry cells and mulberry bodies are useful tool to detect late-onset Fabry disease.
CEN Case Rep. 2017 Nov;6(2):148-151. doi: 10.1007/s13730-017-0262-5. Epub 2017 Jun 7.
3
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy.
Case Rep Nephrol Dial. 2021 Nov 29;11(3):355-361. doi: 10.1159/000520157. eCollection 2021 Sep-Dec.
4
A Renal Variant of Fabry Disease Diagnosed by the Presence of Urinary Mulberry Cells.
Intern Med. 2016;55(23):3475-3478. doi: 10.2169/internalmedicine.55.7367. Epub 2016 Dec 1.
5
A Cardiac Variant of Fabry Disease Diagnosed with Chance Urinary Mulberry Cells.
Intern Med. 2018 Dec 1;57(23):3385-3388. doi: 10.2169/internalmedicine.1177-18. Epub 2018 Jul 6.
6
Anderson-Fabry disease: a multiorgan disease.
Curr Pharm Des. 2013;19(33):5974-96. doi: 10.2174/13816128113199990352.
7
8
Mulberry bodies in the urine sediment of a patient with chronic kidney disease.
Adv Lab Med. 2020 May 5;1(3):20200028. doi: 10.1515/almed-2020-0028. eCollection 2020 Oct.
10
Fabry's disease discovered with chance urinary mulberry cells: a case report.
CEN Case Rep. 2013 May;2(1):49-52. doi: 10.1007/s13730-012-0038-x. Epub 2012 Oct 31.

引用本文的文献

3
Mulberry bodies in the urine sediment of a patient with chronic kidney disease.
Adv Lab Med. 2020 May 5;1(3):20200028. doi: 10.1515/almed-2020-0028. eCollection 2020 Oct.
4
Clinical utility of urinary mulberry bodies/cells testing in the diagnosis of Fabry disease.
Mol Genet Metab Rep. 2023 Jun 7;36:100983. doi: 10.1016/j.ymgmr.2023.100983. eCollection 2023 Sep.
5
Early onset of nephrogenic diabetes insipidus due to fabry disease in a child with N215S mutation: Case report and literature review.
Heliyon. 2023 May 6;9(5):e15993. doi: 10.1016/j.heliyon.2023.e15993. eCollection 2023 May.
6
Fabry Nephropathy in a Young Female Patient Presenting with Only Urinary Mulberry Bodies Treated with Chaperone Therapy.
Case Rep Nephrol Dial. 2021 Nov 29;11(3):355-361. doi: 10.1159/000520157. eCollection 2021 Sep-Dec.
7
Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease.
Intern Med. 2020;59(7):971-976. doi: 10.2169/internalmedicine.3813-19. Epub 2020 Apr 1.
10
Fabry Disease with Pacemaker Implantation as the Initial Event.
Intern Med. 2019 Oct 15;58(20):2993-3000. doi: 10.2169/internalmedicine.2468-18. Epub 2019 Jun 27.

本文引用的文献

1
Fabry's disease discovered with chance urinary mulberry cells: a case report.
CEN Case Rep. 2013 May;2(1):49-52. doi: 10.1007/s13730-012-0038-x. Epub 2012 Oct 31.
2
A Renal Variant of Fabry Disease Diagnosed by the Presence of Urinary Mulberry Cells.
Intern Med. 2016;55(23):3475-3478. doi: 10.2169/internalmedicine.55.7367. Epub 2016 Dec 1.
3
Fabry Disease Diagnosed Based on the Detection of Urinary Mulberry Bodies.
Intern Med. 2016;55(19):2903. doi: 10.2169/internalmedicine.55.7084. Epub 2016 Oct 1.
4
Lipiduria--with special relevance to Fabry disease.
Clin Chem Lab Med. 2015 Nov;53 Suppl 2:s1465-70. doi: 10.1515/cclm-2015-0499.
5
Copious Podocyturia without Proteinuria and with Normal Renal Function in a Young Adult with Fabry Disease.
Case Rep Nephrol. 2015;2015:257628. doi: 10.1155/2015/257628. Epub 2015 May 21.
7
The kidney in Fabry's disease.
Clin Genet. 2014 Oct;86(4):301-9. doi: 10.1111/cge.12386. Epub 2014 May 30.
8
Agalsidase benefits renal histology in young patients with Fabry disease.
J Am Soc Nephrol. 2013 Jan;24(1):137-48. doi: 10.1681/ASN.2012030316.
9
Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.
Nephrol Dial Transplant. 2013 Mar;28(3):505-17. doi: 10.1093/ndt/gfs526. Epub 2012 Dec 12.
10
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.
Kidney Int. 2011 Mar;79(6):663-670. doi: 10.1038/ki.2010.484. Epub 2010 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验